Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience.

Eur J Pharmacol

Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University Medical Center, Leiden University, PO Box 9502, 2300 RA Leiden, The Netherlands.

Published: April 2008

Why some individuals thrive and others break down under similar adverse conditions, is a central question in the neuroendocrinology of stress related psychopathology. The brain mineralocorticoid (MR) and glucocorticoid receptors (GR) operate in balance to coordinate behavioural, autonomic and neuroendocrine response patterns involved in homeostasis and health. Genetic variants of both the MR and GR have been functionally characterized. The four GR-gene single nucleotide polymorphisms (SNPs) (ER22/23EK (allele frequency: 3%), N363S (4%), BclI (37%), A3669G (15%)) and the two MR-gene SNPs (-2 G/C (50%), MR-I180V (11%)) showed in vitro changes in transactivational capacity, or affect stability of the mRNA (GR exon 9beta A3669G). All of these MR-and GR-SNPs change the regulation of the hypothalamus-pituitary-adrenal (HPA) axis at different levels including basal level (-2 G/C), dexamethasone induced negative feedback (ER22/23EK, N363S, BclI, 9beta A3669G) or following a psychosocial stress test (Trier Social Stress Test (TSST); all of the MR-and GR-SNPs). Importantly, the MR-I180V increased autonomic output and enhanced cortisol secretion during the TSST. Recently, several of these MR-and GR-variants have been found associated with psychopathology (depression, bipolar disorder). These data provide evidence that dysregulation of MR and GR are causative in the pathogenesis of depression and that these MR-and GR-gene variants are part of the genetic make up that determines individual stress-responsivity and coping style, affecting vulnerability to disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2007.11.072DOI Listing

Publication Analysis

Top Keywords

n363s bcli
8
9beta a3669g
8
mr-and gr-snps
8
stress test
8
tsst mr-and
8
corticosteroid receptor
4
receptor polymorphisms
4
polymorphisms determinants
4
determinants vulnerability
4
vulnerability resilience
4

Similar Publications

Article Synopsis
  • The study looked at how certain gene variations (BclI, ER22/23EK, N363S) affect a condition called lacrimal gland benign lymphoepithelial lesion (LGBLEL) and how well patients respond to steroid treatments (glucocorticoids).
  • They tested blood samples from 52 patients and 10 healthy people, as well as examined tissue samples from surgeries.
  • The findings suggested that patients with a specific gene variant (BclI allele C) might respond better to treatments and have less severe symptoms, which could help doctors decide on better treatment plans for these patients.
View Article and Find Full Text PDF

Aims: The effect of excess glucocorticoid receptor (GR) stimulation through glucocorticoid medication or cortisol on glucose metabolism is well established. There are genetic GR variants that result in increased or decreased GR stimulation. We aimed to determine the prevalence of genetic GR variants in different ethnic groups in a cohort of patients with type 2 diabetes, and we aimed to determine their association with age of diabetes onset and metabolic and inflammation parameters.

View Article and Find Full Text PDF
Article Synopsis
  • Research indicates that early-life adversity, such as prenatal famine, can heighten the risk of developing PTSD later in life, influenced by genetic factors during critical developmental phases.
  • A study of 439 adults born during the Dutch Famine examined how variations in the glucocorticoid receptor (GR) gene affect PTSD symptoms linked to early trauma and later life stressors.
  • Findings revealed that individuals without the GR Bl haplotype—who were exposed to famine in early gestation—had a stronger relationship between adulthood trauma and PTSD symptoms, highlighting the complex interplay between genetics and environmental factors in mental health outcomes.
View Article and Find Full Text PDF

Introduction: Glucocorticoids (GCs) are commonly prescribed as immunosuppressive agents after kidney transplantation and their most common non-traumatic adverse effect is Avascular Necrosis (AVN) of the femoral head. In this regard, this study aimed to evaluate the glucocorticoid receptor (GR) polymorphisms among kidney transplant recipients and their potential role as a risk factor for the incidence of AVN.

Methods: In this study, 99 renal transplant recipients were evaluated for the correlations of GR polymorphisms including N363S (rs6195), BclI (rs41423247), ER22/23EK (rs6189/rs6190), and A3669G (rs6198) with AVN after renal transplantation.

View Article and Find Full Text PDF

Context: Patients with endogenous Cushing's syndrome (CS) may suffer from a wide range of neuropsychiatric symptoms leading to impaired quality of life (QoL).

Objective: Glucocorticoid receptor (GR) polymorphisms are associated with increased (BclI and N363S) or decreased (A3669G and ER22/23EK) GR sensitivity.

Hypothesis: GR genotypes may modulate and affect QoL and recovery after remission differently via GR sensitivity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!